Earli

Earli Inc. is a developer of cancer diagnostic devices aimed at identifying natural biomarkers. The company's device forces cancer cells to synthesize biomarkers not native to the human body, which are then detected in blood, urine, or breath to track and eliminate cancer. This allows patients to directly obtain rapid treatment response data from the cancer, enabling personalized treatment and early detection of metastasis.